NasdaqCM - Nasdaq Real Time Price USD

OKYO Pharma Limited (OKYO)

1.4702 +0.0202 (+1.39%)
As of 2:04 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Operating Expense
13,187.2000
13,187.2000
6,217.5660
3,366.2060
Operating Income
-13,187.2000
-13,187.2000
-6,217.5660
-3,366.2060
Net Non Operating Interest Income Expense
-96.6870
-96.6870
--
-1.1230
Other Income Expense
--
--
--
-11.1720
Pretax Income
-13,283.8870
-13,283.8870
-6,217.5660
-3,378.5010
Tax Provision
-12.2020
-12.2020
-786.5210
-24.9940
Net Income Common Stockholders
-13,271.6850
-13,271.6850
-5,431.0450
-3,353.5070
Diluted NI Available to Com Stockholders
-13,271.6850
-13,271.6850
-5,431.0450
-3,353.5070
Basic EPS
-0.61
-0.61
-0.36
-0.32
Diluted EPS
-0.61
-0.61
-0.36
-0.32
Basic Average Shares
22,257.0580
22,257.0580
15,064.8130
10,350.2710
Diluted Average Shares
22,257.0580
22,257.0580
798,259.3560
10,350.2710
Total Operating Income as Reported
--
--
--
-4,133.3498
Total Expenses
13,187.2000
13,187.2000
6,217.5660
3,366.2060
Net Income from Continuing & Discontinued Operation
-13,271.6850
-13,271.6850
-5,431.0450
-3,353.5070
Normalized Income
-13,271.6850
-13,271.6850
-5,431.0450
-3,342.4176
Interest Expense
96.6870
96.6870
--
1.1230
Net Interest Income
-96.6870
-96.6870
--
-1.1230
EBIT
-13,187.2000
-13,187.2000
-6,217.5660
-3,377.3780
EBITDA
-13,183.4030
-13,183.4030
-6,215.2350
-3,364.2670
Reconciled Depreciation
3.7970
3.7970
2.3310
13.1110
Net Income from Continuing Operation Net Minority Interest
-13,271.6850
-13,271.6850
-5,431.0450
-3,353.5070
Total Unusual Items Excluding Goodwill
--
--
--
-11.1720
Total Unusual Items
--
--
--
-11.1720
Normalized EBITDA
-13,183.4030
-13,183.4030
-6,215.2350
-3,353.0950
Tax Rate for Calcs
0.0000
0.0000
0.0001
0.0000
Tax Effect of Unusual Items
--
--
--
-0.0826
3/31/2021 - 5/17/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CMRA Comera Life Sciences Holdings, Inc.
0.0361
0.00%
 
IPHA Innate Pharma S.A.
2.4100
+0.42%
 
688222.SS HitGen Inc.
12.98
+3.02%
 
3DMA.SG Kintara Therapeutics Inc
0.1884
+34.76%
 
DRMAW Dermata Therapeutics, Inc.
0.0095
+3.26%
 
ELVAF Evolva Holding SA
1.1000
0.00%
 
SABSW SAB Biotherapeutics, Inc.
0.0300
0.00%
 
XBIOW Xenetic Biosciences, Inc.
7.46
-17.11%
 
HVO.IR hVIVO plc
0.3200
0.00%
 
ARTLW Artelo Biosciences, Inc.
0.0118
0.00%